Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFIRFI Meaning: What Is an RFI?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›6550--Molecular Oncology-MSI Testing

U.S. Department Of Veterans Affairs·Arizona

6550--Molecular Oncology-MSI Testing

Closes 4/23/2026$5k – $50kRequest for Information
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs (VA) is seeking sources that can provide MSI Testing Reagent Cartridges as Reagent Rental for in-house single gene molecular testing. The assay should be fully automated, provide results in approximately 150 minutes, and detect mutations in 7 novel MSI loci. The VA is looking for companies that can provide this service and is requesting information on company size, capabilities, and pricing. Some key points to consider are: • The assay should be fully automated and ready to use with no reagent preparation required. • The assay should provide a result in approximately 150 minutes. • No sample extraction is required prior to use. • The testing volume should be able to be performed on a minimum of 1 slice of FFPE tissue section. • The assay should eliminate the use of external quality control. • The assay should provide qualitative detection of mutations in 7 novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2).

Attached files

Contact

Samuel Han(Contract Specialist)

[email protected]

(562) 766-2314

Key dates

Opened
4/17/2026
Closes
4/23/2026

Last updated

Details

Type
Request for Information
Industry
Healthcare and Medical Services
NAICS
325413
Solicitation №
36C26226Q0668

Budget estimate

$5,000 – $50,000

The budget for this opportunity is difficult to estimate, as it is a Request for Information (RFI) and not a solicitation announcement. However, based on the information provided, it appears that the VA is looking for a supplier of MSI Testing Reagent Cartridges, which could be a relatively low-cost item. The estimated annual quantity of the cartridges is 50, and the cost of each cartridge could range from $100 to $1,000, depending on the manufacturer and the specific product. Therefore, the total budget for this opportunity could be in the range of $5,000 to $50,000 per year.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 73%

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

72% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

71% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

71% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

71% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

70% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

70% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

70% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

70% match

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Closes 5/27/2027Opened 6/24/2026

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

69% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

69% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Department Of Health And Human Services·Maryland

69% match

NOI - DNA Sequencing of Bone Marrow Failure Syndro

Closes 11/2/2026Opened 10/22/2026

U.S. National Institutes of Health·United States of America

69% match

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. Department Of Health And Human Services·Maryland

69% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

69% match

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

Massachusetts Department of Public Health·Massachusetts

69% match

RFR 257030 Certified Oncology Data Specialist

Closes 6/30/2030Opened 3/6/2025

U.S. National Institutes of Health·United States of America

68% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. Department Of Veterans Affairs·Maryland

68% match

6550--Cepheid GeneXpert Testing Supplies

Closes 11/16/2026Opened 9/22/2026

U.S. National Institutes of Health·United States of America

68% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

68% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

Mental Health, NYS Office of·New York

68% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

68% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

67% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

U.S. National Institutes of Health·United States of America

67% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023